Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol
Eleftheriou, Despina, Moraes, Yolanda Collaco, Purvis, Cara, Pursell, Molly, Morillas, Marta Merida, Kahn, Robin, Mossberg, Maria, Kucera, Filip, Tulloh, Robert, Standing, Joseph F, Swallow, Veronica, McCormack, Rachael, Herberg, Jethro, Levin, Michael, Wan, Mandy, Klein, Nigel, Connon, Roisin, Walker, Ann Sarah, Brogan, Paul
Published in Current controlled trials in cardiovascular medicine (26.01.2023)
Published in Current controlled trials in cardiovascular medicine (26.01.2023)
Get full text
Journal Article
Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin trial protocol
Eleftheriou, Despina, Moraes, Yolanda Collaco, Purvis, Cara, Pursell, Molly, Morillas, Marta Merida, Kahn, Robin, Mossberg, Maria, Kucera, Filip, Tulloh, Robert, Standing, Joseph F, Swallow, Veronica, McCormack, Rachael, Herberg, Jethro, Levin, Michael, Wan, Mandy, Klein, Nigel, Connon, Roisin, Walker, Ann Sarah, Brogan, Paul
Published in Trials (26.01.2023)
Published in Trials (26.01.2023)
Get full text
Journal Article